
This study evaluated factors affecting the duration of the infusion appointment times for 392 clinical trial patients.

This study evaluated factors affecting the duration of the infusion appointment times for 392 clinical trial patients.

Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.